Announced
Financials
Sources
Tags
pharmaceutical software provider
Private
China
Software
Majority
Venture Capital
Private Equity
Pending
Single Bidder
Acquisition
Friendly
Synopsis
Taimei Technology, a Chinese cloud-based software provider that serves pharmaceutical companies and clinical research organizations, completed Series E and Series E+ rounds of financing at $212m. Taimei Technology operates as a technology solution provider in the field of life sciences with a focus on clinical research and pharmacovigilance, which is also known as drug safety, is related to the collection, detection, assessment, monitoring, and prevention of adverse effects of pharmaceutical products.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.